Cancer Therapies to 2009

TABLE OF CONTENTS

INTRODUCTION

I. EXECUTIVE SUMMARY

II. MARKET ENVIRONMENT

General

Economic Environment

Cyclical Trends

Long-Term Trends

Demographic Patterns

Health Care Environment

Health Insurance & Reimbursement

Medical Conditions

Acute Conditions

Chronic Conditions

Cancer Incidence & Indicators

National Health Expenditures

Medical Providers

Pharmaceuticals Industry Overview

Biotechnology Industry Overview

Cost/Pricing Dynamics

Regulatory Environment

Multinational Dynamics

World Cancer Therapies Market

Trends in US Foreign Trade

III. TECHNOLOGY

General

Traditional Cancer Treatments

Surgery

Radiation

Chemotherapy

Advanced Cancer Therapies

Biotechnology-Based

Cancer Vaccines

Nanotechnology-Based

Stem Cells

Chemotherapy Adjuvants

Therapy Delivery Systems

Other Technological Issues

Cancer Screening & Imaging Systems

Health Care Information Systems

IV. PRODUCTS & SERVICES

General

Therapies by Type of Cancer

Breast

Digestive System

Genital System

Leukemia

Lymphoma

Respiratory System

Skin

Urinary System

Other

Therapies by Product/Procedure

Chemotherapy Drugs

Mitotic Inhibitors

Antimetabolites

Alkylating Agents

Other Types

Surgery

Radiation Therapy

Biotechnology-Based Drugs

Other/Advanced

Hormonal Therapy

Vaccines

Nanotechnology

Stem Cells & Other

General

Hospitals

Market Overview

Cancer Therapies Outlook

Outpatient Facilities

Market Overview

Cancer Therapies Outlook

Physicians Offices

Market Overview

Cancer Therapies Outlook

Other Markets

Home Health Care

Educational & Research Institutions

VI. INDUSTRY STRUCTURE

General

Industry Composition & Market Share

Research & Product Development

Manufacturing

Marketing & Distribution

Financial Issues & Requirements

Mergers, Acquisitions & Industry Restructuring

Strategic Partnerships

COMPANY PROFILES

Albany Molecular Research Incorporated

American Pharmaceutical Partners Incorporated

Amgen Incorporated

AstraZeneca plc

Aton Pharma Incorporated, see Merck & Company

Incorporated

Aventis Pharmaceuticals Incorporated, see Sanofi-Aventis

Biogen Idec Incorporated

Bristol-Myers Squibb Company

Cell Pathways Incorporated, see OSI Pharmaceuticals

Incorporated

Cell Therapeutics Incorporated

Cephalon Incorporated

CIMA LABS Incorporated, see Cephalon Incorporated

Corixa Corporation, see GlaxoSmithKline plc

Genentech Incorporated

Genzyme Corporation

GlaxoSmithKline plc

Hoffmann-La Roche Incorporated, see Roche Holding

Limited

ILEX Oncology Incorporated, see Genzyme Corporation

ImClone Systems Incorporated

Johnson & Johnson

Kirin-Amgen Incorporated, see Amgen Incorporated

Ligand Pharmaceuticals Incorporated

Lilly (Eli) and Company

Merck & Company Incorporated

MGI Pharma Incorporated

Millennium Pharmaceuticals Incorporated

Novartis International AG

Ortho Biotech Products LP, see Johnson & Johnson

OSI Pharmaceuticals Incorporated

Pfizer Incorporated

Pharmion Corporation

Radiation Therapy Services Incorporated

Roche Holding Limited

Salmedix Incorporated, see Cephalon Incorporated

Sanofi-Aventis

Sanofi-Synthelabo Incorporated, see Sanofi-Aventis

Schering-Plough Corporation

Therakos Incorporated, see Johnson & Johnson

Tibotec Therapeutics, see Johnson & Johnson

Tularik Incorporated, see Amgen Incorporated

21st Century Oncology Incorporated, see Radiation Therapy

Services Incorporated

US Oncology Incorporated

Wyeth

Zycos Incorporated, see MGI Pharma Incorporated

Other Companies Mentioned in Study

LIST OF TABLES

SECTION I -- EXECUTIVE SUMMARY

Summary Table

SECTION II -- MARKET ENVIRONMENT

1 Macroeconomic Environment

2 Cancer Therapies Market Trends, 1994-2004

3 Resident Population by Age & Sex

4 Health Care Indicators

5 Medical Conditions

6 Cancer Incidences & Deaths

7 National Health Expenditures

8 Medical Providers

9 Pharmaceuticals & Biotechnology Market Indicators

10 World Cancer Therapies Market

11 US Foreign Trade in Cancer Therapy Drugs

SECTION IV -- PRODUCTS & SERVICES

1 Cancer Therapies Demand

2 Therapies Demand by Type of Cancer

3 Breast Cancer Therapies Demand

4 Digestive System Cancer Therapies Demand

5 Genital System Cancer Therapies Demand

6 Leukemia Therapies Demand

7 Lymphoma Therapies Demand

8 Respiratory System Cancer Therapies Demand

9 Skin Cancer Therapies Demand

10 Urinary System Cancer Therapies Demand

11 Other Cancers Therapies Demand

12 Therapies Demand by Product/Procedure

13 Chemotherapy Drugs Demand

14 Cancer Surgery Demand

15 Cancer Radiation Therapy Demand

16 Biotechnology-Based Cancer Drugs Demand

17 Other/Advanced Cancer Therapies Demand

SECTION V -- MARKETS

1 Cancer Therapies Market by Institution/Provider

2 Hospital Indicators

3 Hospital Cancer Therapies Market

4 Outpatient Facilities Indicators

5 Outpatient Facilities Cancer Therapies Market

6 Physicians Indicators

7 Physicians Offices Cancer Therapies Market

8 Other Cancer Therapies Markets

SECTION VI -- INDUSTRY STRUCTURE

1 Research & Development Spending Patterns: Selected

Cancer Therapy Companies

2 Capital Spending Patterns: Selected Cancer Therapy

Companies

3 Composite Financial Ratios: Selected Cancer Therapy

Companies, 2004

4 Selected Acquisitions & Divestitures

5 Selected Strategic Partnerships

6 Revenue & Profits Data: Selected Cancer Therapy

Companies, 2004

LIST OF CHARTS

SECTION II -- MARKET ENVIRONMENT

1 Cancer Therapies Market Volatility

2 New Cancer Incidences by Type, 2004

3 Cancer Therapies Pricing Patterns, 1994-2014

SECTION IV -- PRODUCTS & SERVICES

1 Cancer Therapies Demand by Type of Cancer, 2004

2 Cancer Therapies Demand by Product/Procedure, 2004

SECTION V -- MARKETS

1 Cancer Therapies Market by Institution/Provider, 2004

SECTION VI -- INDUSTRY STRUCTURE

1 US Cancer Therapies Market Share by Company, 2004